individualization of immunosuppressive therapy. In addition, it might be applied for realizing
the early and non-invasive diagnosis of acute allograft rejection. Methods Percentages of
TCD4+ IL-17+(Th17) and TCD4+ CD25+ CD127 dim/−(Treg) cells, as well as serum levels
of interleukin (IL)-17 and transforming growth factor (TGF)-β1, were evaluated in 30 stable
patients using flow cytometry and ELISA techniques before and six months after liver …